private:igenica
|
3141252
|
Feb 17th, 2018 12:00AM
|
Igenica Biotherapeutics, Inc.
|
582
|
9.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
|
|
|
|
|
|
|
|
|
|
Igenica
|
|
Health Care Equipment & Services
|
private:igenica
|
3141252
|
Feb 16th, 2018 12:00AM
|
Igenica Biotherapeutics, Inc.
|
582
|
9.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
|
|
|
|
|
|
|
|
|
|
Igenica
|
|
Health Care Equipment & Services
|
private:igenica
|
3141252
|
Feb 15th, 2018 12:00AM
|
Igenica Biotherapeutics, Inc.
|
582
|
9.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
|
|
|
|
|
|
|
|
|
|
Igenica
|
|
Health Care Equipment & Services
|
private:igenica
|
3141252
|
Feb 14th, 2018 12:00AM
|
Igenica Biotherapeutics, Inc.
|
582
|
9.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
|
|
|
|
|
|
|
|
|
|
Igenica
|
|
Health Care Equipment & Services
|
private:igenica
|
3141252
|
Feb 13th, 2018 12:00AM
|
Igenica Biotherapeutics, Inc.
|
582
|
9.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
|
|
|
|
|
|
|
|
|
|
Igenica
|
|
Health Care Equipment & Services
|
private:igenica
|
3141252
|
Feb 12th, 2018 12:00AM
|
Igenica Biotherapeutics, Inc.
|
582
|
9.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
|
|
|
|
|
|
|
|
|
|
Igenica
|
|
Health Care Equipment & Services
|
private:igenica
|
3141252
|
Feb 11th, 2018 12:00AM
|
Igenica Biotherapeutics, Inc.
|
582
|
9.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
|
|
|
|
|
|
|
|
|
|
Igenica
|
|
Health Care Equipment & Services
|
private:igenica
|
3141252
|
Feb 10th, 2018 12:00AM
|
Igenica Biotherapeutics, Inc.
|
582
|
9.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
|
|
|
|
|
|
|
|
|
|
Igenica
|
|
Health Care Equipment & Services
|
private:igenica
|
3141252
|
Feb 9th, 2018 12:00AM
|
Igenica Biotherapeutics, Inc.
|
582
|
9.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
|
|
|
|
|
|
|
|
|
|
Igenica
|
|
Health Care Equipment & Services
|
private:igenica
|
3141252
|
Feb 8th, 2018 12:00AM
|
Igenica Biotherapeutics, Inc.
|
582
|
9.00
|
Open
|
Biotechnology
|
Feb 8th, 2017 11:57AM
|
Feb 8th, 2017 11:57AM
|
Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
|
|
|
|
|
|
|
|
|
|
Igenica
|
|
Health Care Equipment & Services
|